Waldencastの空売り状況は、投資家がWaldencastの株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

Waldencast (NASDAQ:WALD) 株価情報, 空売り情報

Waldencast

Waldencast PLC is a beauty and wellness operating platform by developing, acquiring, accelerating, and scaling the next generation of conscious, purpose-driven brands. It is organized into two reportable segments namely Obagi Skincare and Milk Makeup.

Waldencast PLC

<p>Citigroup  analyst Keith Horowitz   maintains Regions Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RF#NYSE">RF</a>) with a Buy and lowers the price target from $30 to $28.</p>


News

Price Target

Analyst Ratings

Citigroup Maintains Buy on Regions Finl, Lowers Price Target to $28

<p>&nbsp;<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4381996-1&amp;h=1846396181&amp;u=http%3A%2F%2Fwww.vuzix.com%2Fhome%2F&amp;a=Vuzix%C2%AE+Corporation">Vuzix&#xAE; Corporation</a>&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VUZI#NASDAQ">VUZI</a>), ("Vuzix" or, the "Company"), a leading supplier of AI driven smart glasses, waveguides and augmented reality (AR) technologies, today announced that Xander&#x2122;, a Raleigh, North Carolina-based company, has placed its largest re-order to date for Vuzix Shield&#x2122; smart glasses. This order supports the increasing customer demand for the XanderGlasses&#x2122; solution, a product and software offering that provides real-time captions to assist people with auditory disorders.</p>
<p>XanderGlasses utilize Vuzix Shield smart glasses and are ready to go out of the box. Just push a button, put the glasses on, and you'll see real-time captions of what other people are saying in conversations — directly in the user's field of view, facilitating seamless communication for individuals with hearing challenges. XanderGlasses are 100% self-contained, designed for ease of use, they operate with a simple 'on' and 'off' function and do not require a smartphone or cloud connectivity, ensuring reliability and privacy. This makes them suitable for various environments, including home, work, and public spaces. The lenses have full UV protection, and meet the highest safety standards, ANSI Z87.1 certification.</p>
<p>"With 48 million people in the U.S. experiencing hearing loss, a number that continues to rise, XanderGlasses empower individuals to 'see' what others are saying," explains Alex Westner, Co-Founder and CEO of Xander. "Our team has worked closely with individuals at all stages of hearing loss to develop a simple and reliable solution that meets real-world needs."</p>


VUZI

Vuzix Announces Re-Order From Xander For Vuzix Shield Smart Glasses To Support Demand For XanderGlasses Solution

<p><strong>DailyDelta</strong> officially stepped into the <a href="https://www.benzinga.com/etfs">ETF market </a>with the launch of two new funds: the <strong>DailyDelta Q100 Upside Option Strategy ETF</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QUP#NYSE">QUP</a>) and the <strong>DailyDelta Q100 Downside Option Strategy ETF</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QDWN#NYSE">QDWN</a>). </p>
<p>With these ETFs, investors can track the Nasdaq-100 Index&#8217;s daily fluctuations while finding opportunities to profit from market movements in both directions.</p>
<p>Investors seeking gains from daily Nasdaq-100 downturns can find QDWN ideal as it follows the performance of the top 100 nonfinancial Nasdaq-listed companies. The fund seeks to replicate the negative performance of the index while restricting daily losses to a maximum of 10% of its net asset value. </p>
<p>The fund gains from Nasdaq-100 declines through its primary investment in cash-settled index put options which deliver cash instead of stocks. To protect against the rapid expiration of its put options which can last as little as one trading day, QDWN keeps about 90% of its assets invested in short-term U.S. Treasury securities.</p>
<p><strong>Also Read: <a href="https://www.benzinga.com/25/03/44259396/short-term-bond-etfs-see-record-inflows-amid-market-turmoil-3-funds-that-led-the-surge">Short-Term Bond ETFs See Record Inflows Amid Market Turmoil: 3 Funds That Led The Surge</a></strong></p>
<p>QUP targets investors seeking daily performance benefits from Nasdaq-100 index movements. The fund aims to boost index gains while ensuring daily losses do not exceed 10%. It achieves this goal by purchasing cash-settled call options, which supply leveraged exposure to upward movements in the index.</p>
<p>QUP and QDWN both come with an expense ratio of 1.35%.</p>
<p>The ongoing concern about market volatility is leading to an increased demand for investment strategies that effectively manage daily fluctuations. DailyDelta already registered several new ETFs targeting the<strong> Russell 2000 Index</strong> and<strong> S&amp;P 500 Index</strong> in a recent filing. The upcoming funds include:</p>
<ul>
<li><strong>DailyDeltaTM SP500 Upside Option Strategy ETF </strong>(SXUP)</li>
<li><strong>DailyDeltaTM SP500 Downside Option Strategy ETF </strong>(SDWN)</li>
<li><strong>DailyDeltaTM R2000 Upside Option Strategy ETF</strong> (RUP)</li>
<li><strong>DailyDeltaTM R2000 Downside Option Strategy ETF</strong> (RDWN)</li>
</ul>
<p><strong>Read Next: </strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/etfs/new-etfs/25/03/44281017/new-etf-balances-sp-500-exposure-with-treasury-stability-to-limit-losses">New ETF Balances S&amp;P 500 Exposure With Treasury Stability To Limit Losses</a></strong></li>
</ul>
<p><em>Photo: T. Schneider via Shutterstock</em></p>


New ETFs

ETFs

QDWN

DailyDelta Rolls Out ETFs For Daily Nasdaq-100 Index Movements

<p>Citigroup  analyst Tyler Radke   maintains Oracle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>) with a Neutral and lowers the price target from $194 to $160.</p>


ORCL

Citigroup Maintains Neutral on Oracle, Lowers Price Target to $160

<p>Traders found relief in a cooler-than-expected inflation report, driving tech-heavy indices to a rebound on Wednesday <a href="https://www.benzinga.com/economics/macro-economic-events/25/03/44274165/inflation-cools-more-than-expected-in-february-strengthens-the-case-for-fed-rate-cuts">despite ongoing trade tensions.</a></p>
<p>In February, the Consumer Price Index declined from 3% year-over-year to 2.8%, beating analysts' expectations of a slowdown to 2.9%. Core inflation also dropped more than anticipated, easing from 3.3% to 3.1%.</p>
<p>The decline was supported by contractions in key categories, with gasoline prices falling 1% month-over-month and transportation costs down 0.8%. Airline fares saw a sharper drop, contracting by 4%.</p>
<p>The softer inflation data strengthened expectations for Federal Reserve rate cuts, with traders now assigning nearly an 80% probability of a reduction by June, according to CME's FedWatch Tool.</p>
<p>While inflation relief fueled optimism, trade concerns lingered. The U.S. imposed 25% tariffs on steel and aluminum in April, prompting swift retaliation. In response, the EU introduced tariffs on €26 billion worth of U.S. goods, while Canada imposed additional levies on $29.8 billion, supplementing previous penalties.</p>
<p>The S&amp;P 500 rose 0.6%, while the Nasdaq 100 jumped 1.2%, aiming to break a two-session losing streak. In contrast, the Dow remained flat. </p>
<p>Tech stocks led the rebound from their recent sell-off, with <strong>Palantir Technologies Inc. </strong>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>), <strong>Nvidia Corp. </strong>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), and <strong>Tesla Inc.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) rallying 6.2%, 6.4%, and 7.5%, respectively.</p>
<p>Treasury yields remained flat on the day, while gold climbed 0.8% to $2,940 per ounce, now just 0.5% below its all-time high.</p>
<p><strong>Bitcoin</strong> (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) edged down 0.8%.</p>
<h2 class="wp-block-heading">Wednesday&#8217;s Performance In Major US Indices</h2>
<p><figure class="wp-block-table is-style-stripes"><br />
<table>
<tbody>
<tr>
<td><strong>Major Indices</strong></td>
<td><strong>Price</strong></td>
<td><strong>%</strong></td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>19,625.52</td>
<td>1.3%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,606.41</td>
<td>0.6%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,027.44</td>
<td>0.3%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>41,428.96</td>
<td>0.0%</td>
</tr>
</tbody>
</table>
<p><figcaption class="wp-element-caption"><em>Updated at 1:15 p.m. ET</em></figcaption></p></figure></p>
<p><strong>According to&nbsp;<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>&nbsp;data:</strong></p>
<ul>
<li>The&nbsp;<strong>SPDR S&amp;P 500 ETF Trust</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) rose 0.7% to $560.14.</li>
<li>The&nbsp;<strong>SPDR Dow Jones Industrial Average</strong>&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>) flattened at $414.65.</li>
<li>The tech-heavy&nbsp;<strong>Invesco QQQ Trust Series</strong>&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>)&nbsp;rose 1.4% to $478.01.</li>
<li>The&nbsp;<strong>iShares Russell 2000 ETF</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) inched 0.2% higher to 201.20. </li>
<li>The&nbsp;<strong>Technology</strong>&nbsp;<strong>Select Sector SPDR Fund</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>) outperformed, up 1.8%; the&nbsp;<strong>Consumer Staples&nbsp;Select Sector SPDR Fund</strong>&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLP#NYSE">XLP</a>)<strong>&nbsp;</strong>was the worst sector performer, down 1.9%.</li>
</ul>
<h2 class="wp-block-heading">Wednesday&#8217;s Stock Movers</h2>
<ul>
<li><strong>American Airlines Group Inc.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAL#NASDAQ">AAL</a>) tumbled 3.7%, eyeing its tenth negative session over the past eleven as the company issued a negative outlook for the quarter. Meanwhile, Bank of America lowered the stock price target from $19 to $13. </li>
<li><strong>United Airlines Holdings Inc. </strong>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UAL#NASDAQ">UAL</a>) dropped 4.2% after a wave of price target cuts from major banks. Barclays lowered its target from $150 to $140, BofA trimmed it from $125 to $110, and TD Cowen reduced its estimate from $165 to $150.</li>
<li><strong>Intel Corp.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) surged 4.6% after a Reuters report revealed that <strong>Taiwan Semiconductor Manufacturing</strong> <strong>Company</strong> <strong>Ltd</strong>. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) had approached <strong>Nvidia</strong>, <strong>Advanced Micro Devices Inc</strong>. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>), and <strong>Broadcom Inc. </strong>about investing in a joint venture to operate Intel&#8217;s factories.</li>
</ul>
<p><strong>Read now: </strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/25/03/44280431/cpi-reactions">Inflation Moves In The &#8216;Right Direction&#8217; But Forecast Is Hazy, Economist Says</a></strong></li>
</ul>
<p><em>Photo: Shutterstock</em></p>


Equities

Large Cap

Macro Economic Events

Broad U.S. Equity ETFs

Econ #s

Economics

Tech

$BTC

SPDR Dow Jones Industrial Average ETF Trust

INTC

NVDA

PLTR

TSLA

Wall Street Rebounds As Cooling Inflation Draws Tech Dip Buyers: What's Driving Markets Wednesday?

WIIM

AAOI

ALAB

CDNS

CETX

CRDO

CRNC

DELL

IONQ

MASS

MOBBW

NTNX

NVMI

ONTO

QMCO

RGTI

SHOP

SKYT

TDTH

UBXG

VERX

YAAS

Shares of companies within the broader technology sector are trading higher amid a rebound from weakness earlier this week. The sector may be seeing a boost following softer-than-expected February inflation figures.

<p>LifeSci Capital   initiates coverage on Monte Rosa Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLUE#NASDAQ">GLUE</a>) with a Outperform rating and announces Price Target of $19.</p>


Initiation

GLUE

LifeSci Capital Initiates Coverage On Monte Rosa Therapeutics with Outperform Rating, Announces Price Target of $19

<p>Deep-pocketed investors have adopted a bearish approach towards Cava Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAVA#NYSE">CAVA</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in CAVA usually suggests something big is about to happen.</p>
<p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 10 extraordinary options activities for Cava Group. This level of activity is out of the ordinary.</p>
<p>The general mood among these heavyweight investors is divided, with 10% leaning bullish and 90% bearish. Among these notable options, 7 are puts, totaling $369,818, and 3 are calls, amounting to $128,840.</p>
<h3>What's The Price Target?</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $60.0 to $130.0 for Cava Group over the last 3 months. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.</p>
<p>This data can help you track the liquidity and interest for Cava Group's options for a given strike price.</p>
<p>Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Cava Group's whale activity within a strike price range from $60.0 to $130.0 in the last 30 days. </p>
<h3>Cava Group 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1741802559_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th align="right"><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>CAVA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$7.15</td>
<td>$7.1</td>
<td>$7.15</td>
<td>$60.00</td>
<td>$112.9K</td>
<td align="right">450</td>
<td align="right">0</td>
</tr>
<tr>
<td>CAVA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$9.55</td>
<td>$9.5</td>
<td>$9.5</td>
<td>$90.00</td>
<td>$74.1K</td>
<td align="right">155</td>
<td align="right">126</td>
</tr>
<tr>
<td>CAVA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$7.15</td>
<td>$7.1</td>
<td>$7.15</td>
<td>$60.00</td>
<td>$73.6K</td>
<td align="right">450</td>
<td align="right">165</td>
</tr>
<tr>
<td>CAVA</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$49.7</td>
<td>$48.2</td>
<td>$49.4</td>
<td>$130.00</td>
<td>$54.3K</td>
<td align="right">113</td>
<td align="right">4</td>
</tr>
<tr>
<td>CAVA</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>10/17/25</td>
<td>$17.0</td>
<td>$16.85</td>
<td>$17.0</td>
<td>$85.00</td>
<td>$42.5K</td>
<td align="right">156</td>
<td align="right">27</td>
</tr>
</tbody>
</table>
</p>
<h3>About Cava Group</h3>
<p>Cava Group Inc owns and operates a chain of restaurants. It is the category-defining Mediterranean fast-casual restaurant brand, bringing together healthful food and bold, satisfying flavors at scale. The company's dips, spreads, and dressings are centrally produced and sold in grocery stores. The company's operations are conducted as two reportable segments: CAVA and Zoes Kitchen. The company generates all of its revenue from the CAVA segment.</p>
<p>After a thorough review of the options trading surrounding Cava Group, we move to examine the company in more detail. This includes an assessment of its current market status and performance.</p>
<h3>Where Is Cava Group Standing Right Now?</h3>
<ul>
<li>With a trading volume of 1,212,683, the price of CAVA is up by 1.24%, reaching $81.0.</li>
<li>Current RSI values indicate that the stock is may be oversold.</li>
<li>Next earnings report is scheduled for 76 days from now.</li>
</ul>
<h3>What The Experts Say On Cava Group</h3>
<p>In the last month, 5 experts released ratings on this stock with an average target price of $124.8.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; Consistent in their evaluation, an analyst from TD Securities keeps a Buy rating on Cava Group with a target price of $130.<br />
&#x2A; An analyst from Barclays has decided to maintain their Equal-Weight rating on Cava Group, which currently sits at a price target of $104.<br />
&#x2A; An analyst from Wedbush downgraded its action to Outperform with a price target of $150.<br />
&#x2A; Consistent in their evaluation, an analyst from Loop Capital keeps a Hold rating on Cava Group with a target price of $100.<br />
&#x2A; An analyst from Citigroup has decided to maintain their Neutral rating on Cava Group, which currently sits at a price target of $140. </p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Cava Group options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.</p>


Options

Markets

CAVA

What the Options Market Tells Us About Cava Group

<p>Deep-pocketed investors have adopted a bullish approach towards Amgen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMGN#NASDAQ">AMGN</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in AMGN usually suggests something big is about to happen.</p>
<p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 10 extraordinary options activities for Amgen. This level of activity is out of the ordinary.</p>
<p>The general mood among these heavyweight investors is divided, with 70% leaning bullish and 20% bearish. Among these notable options, 5 are puts, totaling $244,892, and 5 are calls, amounting to $666,670.</p>
<h3>Predicted Price Range</h3>
<p>Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $300.0 to $400.0 for Amgen during the past quarter. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Amgen's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Amgen's significant trades, within a strike price range of $300.0 to $400.0, over the past month.</p>
<h3>Amgen 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1741802552_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>AMGN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$0.88</td>
<td>$0.2</td>
<td>$0.83</td>
<td>$400.00</td>
<td>$466.2K</td>
<td>6.1K</td>
<td>6.0K</td>
</tr>
<tr>
<td>AMGN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/20/26</td>
<td>$39.8</td>
<td>$38.9</td>
<td>$39.77</td>
<td>$310.00</td>
<td>$79.3K</td>
<td>11</td>
<td>21</td>
</tr>
<tr>
<td>AMGN</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/14/25</td>
<td>$5.6</td>
<td>$5.05</td>
<td>$5.5</td>
<td>$315.00</td>
<td>$68.7K</td>
<td>884</td>
<td>132</td>
</tr>
<tr>
<td>AMGN</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$26.0</td>
<td>$25.85</td>
<td>$25.85</td>
<td>$320.00</td>
<td>$62.0K</td>
<td>192</td>
<td>65</td>
</tr>
<tr>
<td>AMGN</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/14/25</td>
<td>$2.92</td>
<td>$2.76</td>
<td>$2.76</td>
<td>$310.00</td>
<td>$55.2K</td>
<td>388</td>
<td>320</td>
</tr>
</tbody>
</table>
</p>
<h3>About Amgen</h3>
<p>Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drugs Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx Pharmaceuticals bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brought several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.</p>
<h3>Present Market Standing of Amgen</h3>
<ul>
<li>With a volume of 1,655,254, the price of AMGN is down -1.14% at $315.26. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 50 days.</li>
</ul>
<h3>What Analysts Are Saying About Amgen</h3>
<p>A total of 1 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $294.0.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; Maintaining their stance, an analyst from B of A Securities continues to hold a Underperform rating for Amgen, targeting a price of $294. </p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Amgen options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.</p>


AMGN

Amgen's Options: A Look at What the Big Money is Thinking

<p>Deep-pocketed investors have adopted a bearish approach towards Kenvue (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KVUE#NYSE">KVUE</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in KVUE usually suggests something big is about to happen.</p>
<p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 10 extraordinary options activities for Kenvue. This level of activity is out of the ordinary.</p>
<p>The general mood among these heavyweight investors is divided, with 20% leaning bullish and 60% bearish. Among these notable options, 3 are puts, totaling $139,421, and 7 are calls, amounting to $1,407,967.</p>
<h3>Predicted Price Range</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $20.0 to $23.5 for Kenvue over the last 3 months. </p>
<h3>Analyzing Volume &amp; Open Interest</h3>
<p>In today's trading context, the average open interest for options of Kenvue stands at 2265.0, with a total volume reaching 38,534.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Kenvue, situated within the strike price corridor from $20.0 to $23.5, throughout the last 30 days.</p>
<h3>Kenvue Call and Put Volume: 30-Day Overview</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1741802545_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>KVUE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>05/16/25</td>
<td>$1.3</td>
<td>$1.23</td>
<td>$1.27</td>
<td>$23.00</td>
<td>$704.8K</td>
<td>1.0K</td>
<td>11.0K</td>
</tr>
<tr>
<td>KVUE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$1.25</td>
<td>$1.23</td>
<td>$1.23</td>
<td>$23.00</td>
<td>$305.7K</td>
<td>1.0K</td>
<td>3.8K</td>
</tr>
<tr>
<td>KVUE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$1.21</td>
<td>$1.18</td>
<td>$1.21</td>
<td>$23.00</td>
<td>$152.4K</td>
<td>1.0K</td>
<td>1.3K</td>
</tr>
<tr>
<td>KVUE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>05/16/25</td>
<td>$1.29</td>
<td>$1.27</td>
<td>$1.27</td>
<td>$23.00</td>
<td>$84.0K</td>
<td>1.0K</td>
<td>4.4K</td>
</tr>
<tr>
<td>KVUE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$3.9</td>
<td>$3.8</td>
<td>$3.8</td>
<td>$20.00</td>
<td>$66.5K</td>
<td>190</td>
<td>20</td>
</tr>
</tbody>
</table>
</p>
<h3>About Kenvue</h3>
<p>Kenvue is the world's largest pure-play consumer health company by sales, generating $15 billion in annual revenue. Formerly known as Johnson &amp; Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.</p>
<p>After a thorough review of the options trading surrounding Kenvue, we move to examine the company in more detail. This includes an assessment of its current market status and performance.</p>
<h3>Present Market Standing of Kenvue</h3>
<ul>
<li>Trading volume stands at 5,028,386, with KVUE's price down by -1.6%, positioned at $23.11.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 55 days.</li>
</ul>
<h3>What Analysts Are Saying About Kenvue</h3>
<p>In the last month, 2 experts released ratings on this stock with an average target price of $28.0.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; Consistent in their evaluation, an analyst from Canaccord Genuity keeps a Buy rating on Kenvue with a target price of $29.<br />
&#x2A; Consistent in their evaluation, an analyst from Piper Sandler keeps a Overweight rating on Kenvue with a target price of $27. </p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for Kenvue, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.</p>


KVUE

Behind the Scenes of Kenvue's Latest Options Trends

ABTS

AMOD

APPS

BLBX

BLND

DUOT

FICO

LPSN

PCOR

QBTS

QUBT

SOUN

ZENA

Shares of software companies are trading higher as the tech sector rebounds from weakness earlier this week. The sector may be seeing a boost after a report suggested TSMC pitched a joint venture with several chip designers to operate Intel's factories.

<p>Jefferies  analyst Omar Nokta   maintains Navigator Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVGS#NYSE">NVGS</a>) with a Buy and maintains $20 price target.</p>


NVGS

Jefferies Maintains Buy on Navigator Holdings, Maintains $20 Price Target

<p><a href="https://www.bloomberg.com/news/articles/2025-03-12/mexico-holds-off-tariff-retaliation-as-sheinbaum-bets-on-us-deal" title="https://www.bloomberg.com/news/articles/2025-03-12/mexico-holds-off-tariff-retaliation-as-sheinbaum-bets-on-us-deal">https://www.bloomberg.com/news/articles/2025-03-12/mexico-holds-off-tariff-retaliation-as-sheinbaum-bets-on-us-deal</a></p>


Mexico Delays Its Response To U.S. Tariffs On Steel And Aluminum Imports As President Claudia Sheinbaum Avoids Retaliation While Both Countries Negotiate To Avert Levies On A Wide Range Of Products And Services-Bloomberg

<p>Deep-pocketed investors have adopted a bearish approach towards Nike (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in NKE usually suggests something big is about to happen.</p>
<p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 38 extraordinary options activities for Nike. This level of activity is out of the ordinary.</p>
<p>The general mood among these heavyweight investors is divided, with 31% leaning bullish and 52% bearish. Among these notable options, 19 are puts, totaling $1,287,404, and 19 are calls, amounting to $901,587.</p>
<h3>Predicted Price Range</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $55.0 to $110.0 for Nike over the last 3 months. </p>
<h3>Volume &amp; Open Interest Trends</h3>
<p>In today's trading context, the average open interest for options of Nike stands at 3769.12, with a total volume reaching 11,016.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Nike, situated within the strike price corridor from $55.0 to $110.0, throughout the last 30 days.</p>
<h3>Nike 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1741801612_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>NKE</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$9.65</td>
<td>$9.5</td>
<td>$9.5</td>
<td>$75.00</td>
<td>$475.0K</td>
<td>13.4K</td>
<td align="right">567</td>
</tr>
<tr>
<td>NKE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$3.45</td>
<td>$3.4</td>
<td>$3.4</td>
<td>$95.00</td>
<td>$142.1K</td>
<td>4.1K</td>
<td align="right">0</td>
</tr>
<tr>
<td>NKE</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/28/25</td>
<td>$5.85</td>
<td>$5.75</td>
<td>$5.75</td>
<td>$77.00</td>
<td>$115.0K</td>
<td>1.3K</td>
<td align="right">941</td>
</tr>
<tr>
<td>NKE</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>12/19/25</td>
<td>$10.2</td>
<td>$8.7</td>
<td>$9.45</td>
<td>$75.00</td>
<td>$94.4K</td>
<td>2.5K</td>
<td align="right">100</td>
</tr>
<tr>
<td>NKE</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>03/21/25</td>
<td>$2.0</td>
<td>$1.83</td>
<td>$1.9</td>
<td>$78.00</td>
<td>$76.0K</td>
<td>208</td>
<td align="right">406</td>
</tr>
</tbody>
</table>
</p>
<h3>About Nike</h3>
<p>Nike is the largest athletic footwear and apparel brand in the world. Key categories include basketball, running, and football (soccer). Footwear generates about two thirds of its sales. Its brands include Nike, Jordan (premium athletic footwear and clothing), and Converse (casual footwear). Nike sells products worldwide through company-owned stores, franchised stores, and third-party retailers. The firm also operates e-commerce platforms in more than 40 countries. Nearly all its production is outsourced to contract manufacturers in more than 30 countries. Nike was founded in 1964 and is based in Beaverton, Oregon.</p>
<p>Having examined the options trading patterns of Nike, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance</p>
<h3>Where Is Nike Standing Right Now?</h3>
<ul>
<li>Trading volume stands at 5,733,677, with NKE's price down by -0.53%, positioned at $73.78.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 8 days.</li>
</ul>
<h3>What The Experts Say On Nike</h3>
<p>A total of 3 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $101.67.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Jefferies upgraded its action to Buy with a price target of $115.<br />
&#x2A; An analyst from Guggenheim has revised its rating downward to Buy, adjusting the price target to $110.<br />
&#x2A; Maintaining their stance, an analyst from Telsey Advisory Group continues to hold a Market Perform rating for Nike, targeting a price of $80. </p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Nike options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.</p>


Nike Unusual Options Activity For March 12

<p>Investors with a lot of money to spend have taken a bearish stance on <strong>Marriott International</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAR#NASDAQ">MAR</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with MAR, it often means somebody knows something is about to happen.</p>
<p>So how do we know what these investors just did? </p>
<p>Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 10 uncommon options trades for Marriott International.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 30% bullish and 40%, bearish.</p>
<p>Out of all of the special options we uncovered, 7 are puts, for a total amount of $257,646, and 3 are calls, for a total amount of $162,852.</p>
<h3>What's The Price Target?</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $230.0 to $255.0 for Marriott International over the recent three months. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>In terms of liquidity and interest, the mean open interest for Marriott International options trades today is 133.71 with a total volume of 1,311.00.</p>
<p>In the following chart, we are able to follow the development of volume and open interest of call and put options for Marriott International's big money trades within a strike price range of $230.0 to $255.0 over the last 30 days.</p>
<h3>Marriott International Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1741801607_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th align="right"><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>MAR</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$6.1</td>
<td>$5.6</td>
<td>$5.62</td>
<td>$230.00</td>
<td>$77.5K</td>
<td align="right">268</td>
<td align="right">155</td>
</tr>
<tr>
<td>MAR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$8.3</td>
<td>$7.9</td>
<td>$7.9</td>
<td>$250.00</td>
<td>$71.1K</td>
<td align="right">102</td>
<td align="right">109</td>
</tr>
<tr>
<td>MAR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$12.3</td>
<td>$10.9</td>
<td>$10.9</td>
<td>$237.50</td>
<td>$63.2K</td>
<td align="right">0</td>
<td align="right">62</td>
</tr>
<tr>
<td>MAR</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>04/17/25</td>
<td>$15.0</td>
<td>$14.4</td>
<td>$14.7</td>
<td>$250.00</td>
<td>$44.1K</td>
<td align="right">244</td>
<td align="right">33</td>
</tr>
<tr>
<td>MAR</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/28/25</td>
<td>$7.6</td>
<td>$7.2</td>
<td>$7.6</td>
<td>$240.00</td>
<td>$30.4K</td>
<td align="right">42</td>
<td align="right">40</td>
</tr>
</tbody>
</table>
</p>
<h3>About Marriott International</h3>
<p>Marriott operates 1.7 million rooms across roughly 30 brands. At the end of 2024, luxury represented roughly 10% of total rooms, premium was 43%, select service was 45%, midscale was 1%, and other was 1%. Marriott, Courtyard, and Sheraton are the largest brands, while Autograph, Tribute, Moxy, Aloft, and Element are newer lifestyle brands. Managed and franchised represented 98% of total rooms as of Dec. 31, 2024. North America makes up 62% of total rooms. Managed, franchise, and incentive fees represent the vast majority of revenue and profitability for the company.</p>
<p>Following our analysis of the options activities associated with Marriott International, we pivot to a closer look at the company's own performance.</p>
<h3>Present Market Standing of Marriott International</h3>
<ul>
<li>Trading volume stands at 1,046,317, with MAR's price up by 0.93%, positioned at $248.6.</li>
<li>RSI indicators show the stock to be may be oversold.</li>
<li>Earnings announcement expected in 49 days.</li>
</ul>
<h3>Expert Opinions on Marriott International</h3>
<p>5 market experts have recently issued ratings for this stock, with a consensus target price of $297.0.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; Consistent in their evaluation, an analyst from Truist Securities keeps a Hold rating on Marriott International with a target price of $308.<br />
&#x2A; Maintaining their stance, an analyst from UBS continues to hold a Neutral rating for Marriott International, targeting a price of $301.<br />
&#x2A; An analyst from Mizuho has decided to maintain their Neutral rating on Marriott International, which currently sits at a price target of $293.<br />
&#x2A; Consistent in their evaluation, an analyst from Morgan Stanley keeps a Overweight rating on Marriott International with a target price of $298.<br />
&#x2A; An analyst from Susquehanna has decided to maintain their Neutral rating on Marriott International, which currently sits at a price target of $285. </p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Marriott International with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.</p>


Marriott International Unusual Options Activity For March 12

<p>Investors with a lot of money to spend have taken a bullish stance on <strong>Cloudflare</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NET#NYSE">NET</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with NET, it often means somebody knows something is about to happen.</p>
<p>So how do we know what these investors just did? </p>
<p>Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 9 uncommon options trades for Cloudflare.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 55% bullish and 44%, bearish.</p>
<p>Out of all of the special options we uncovered, 3 are puts, for a total amount of $154,712, and 6 are calls, for a total amount of $268,460.</p>
<h3>What's The Price Target?</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $80.0 and $160.0 for Cloudflare, spanning the last three months.</p>
<h3>Volume &amp; Open Interest Development</h3>
<p>In today's trading context, the average open interest for options of Cloudflare stands at 727.29, with a total volume reaching 767.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Cloudflare, situated within the strike price corridor from $80.0 to $160.0, throughout the last 30 days.</p>
<h3>Cloudflare 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1741801602_0.png" alt="Options Call Chart" /></p>
<h3>Noteworthy Options Activity:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>NET</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$7.95</td>
<td>$7.85</td>
<td>$7.95</td>
<td>$95.00</td>
<td>$59.6K</td>
<td>175</td>
<td align="right">0</td>
</tr>
<tr>
<td>NET</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$41.0</td>
<td>$40.8</td>
<td>$41.0</td>
<td>$160.00</td>
<td>$57.3K</td>
<td>799</td>
<td align="right">14</td>
</tr>
<tr>
<td>NET</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$2.12</td>
<td>$1.87</td>
<td>$1.88</td>
<td>$131.00</td>
<td>$56.4K</td>
<td>0</td>
<td align="right">300</td>
</tr>
<tr>
<td>NET</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$10.3</td>
<td>$10.25</td>
<td>$10.3</td>
<td>$135.00</td>
<td>$51.5K</td>
<td>1.3K</td>
<td align="right">102</td>
</tr>
<tr>
<td>NET</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$10.3</td>
<td>$10.25</td>
<td>$10.3</td>
<td>$135.00</td>
<td>$51.5K</td>
<td>1.3K</td>
<td align="right">52</td>
</tr>
</tbody>
</table>
</p>
<h3>About Cloudflare</h3>
<p>Cloudflare is a software company based in San Francisco, California, that offers security and web performance offerings by utilizing a distributed, serverless content delivery network, or CDN. The firm's edge computing platform, Workers, leverages this network by providing clients the ability to deploy, and execute code without maintaining servers.</p>
<p>After a thorough review of the options trading surrounding Cloudflare, we move to examine the company in more detail. This includes an assessment of its current market status and performance.</p>
<h3>Present Market Standing of Cloudflare</h3>
<ul>
<li>With a trading volume of 1,724,752, the price of NET is up by 2.34%, reaching $122.88.</li>
<li>Current RSI values indicate that the stock is may be oversold.</li>
<li>Next earnings report is scheduled for 50 days from now.</li>
</ul>
<h3>What The Experts Say On Cloudflare</h3>
<p>Over the past month, 1 industry analysts have shared their insights on this stock, proposing an average target price of $185.0.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Needham downgraded its action to Buy with a price target of $185. </p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Cloudflare with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.</p>


Check Out What Whales Are Doing With NET

<p><strong>Apple Inc</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) stock is under <a href="https://www.benzinga.com/25/03/44210592/apples-tumultuous-week-from-siri-delays-legal-battles-and-new-product-teasers-this-week-in-appleverse">serious selling pressure</a>.</p>
<p>Shares of the Cupertino, California-based company are down 10.85% year-to-date, 8.22% in the past month, and 1.56% today alone.</p>
<p><figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="618" height="487" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/12120449/Screenshot-2025-03-12-at-9.02.39-PM.png" alt="" class="wp-image-821290" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/12120449/Screenshot-2025-03-12-at-9.02.39-PM.png 618w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/12120449/Screenshot-2025-03-12-at-9.02.39-PM-300x236.png 300w" sizes="(max-width: 618px) 100vw, 618px" /></a></figure></p>
<p><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1"><em>Chart created using Benzinga Pro</em></a></p>
<p>Apple stock is giving out all ‘Bearish' signals. The stock price languishes below the eight, 20, 50, and 200-day moving averages.</p>
<p>The MACD (moving average convergence/divergence) indicator? A negative 3.23. </p>
<p>The RSI (relative strength index)? At 29.89, the stock is in the oversold territory. This usually triggers a rebound but the lack of buying pressure and the negative MACD do not support it currently, for Apple stock.</p>
<p>Translation: Wall Street isn&#8217;t feeling the love for Apple right now.</p>
<p><strong>Read Also: <a href="https://www.benzinga.com//node/44270009">Apple Doubles Down On Vision Pro With Metallica Concert Experience: But Can Rock Legends Save A $3,499 Headset That&#8217;s Already Being Scaled Back?</a></strong></p>
<h2 class="wp-block-heading">Morgan Stanley Sounds The Alarm On Apple's AI Delay</h2>
<p>And now, Morgan Stanley is turning up the heat, <a href="https://www.benzinga.com//node/44273437">slashing its price target</a> from $275 to $252. The <a href="https://finance.yahoo.com/news/apples-ai-strategy-is-showing-troubling-cracks-150559429.html">reason</a>? </p>
<p>Apple's AI ambitions are running late. The much-anticipated upgrade to Siri — expected to be a game-changer for iPhone upgrades — is now delayed, throwing a wrench into Apple's iPhone sales projections for 2025 and 2026.</p>
<p>The firm is now forecasting flat iPhone shipments in 2025 and a modest 6% growth in 2026, with revenue and EPS projections trailing consensus estimates.</p>
<h2 class="wp-block-heading">AI Setback Threatens Apple's iPhone Sales Outlook</h2>
<p>AI was supposed to be Apple's golden ticket to an iPhone supercycle, but the delay in rolling out Apple Intelligence has left consumers unimpressed. According to Morgan Stanley, half of iPhone owners who skipped the iPhone 16 cited the delayed AI rollout as a reason. </p>
<p>And Apple's biggest rival, <strong>Samsung</strong>, isn't waiting around — its latest devices, packed with Google's <strong>Gemini AI</strong>, are already hitting the market.</p>
<p>Beyond the AI hiccup, Apple is also grappling with a $2 billion tariff-related cost headache in 2025, adding to its list of woes. </p>
<p>While a redesigned iPhone 17 could offer some relief, the reality is that Apple's AI execution is looking more like a stumble than a sprint.</p>
<h2 class="wp-block-heading">Can Apple Recover From Its AI Stumble?</h2>
<p>Apple has seen stumbles before &#8211; AirPods and Apple Watch both started slow before becoming massive hits. </p>
<p>But investors hoping for a quick turnaround might need some patience. The AI race isn't over yet, but for now, Apple is playing catch-up while its stock takes a hit.</p>
<p><strong>Read Next: </strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com//node/44279970">Magnificent 7 Stocks Add $250 Billion In Value After Benign Inflation As Traders Rush To Buy Dips</a></strong></li>
</ul>
<p><em>Image: Shutterstock</em></p>


Analyst Color

Technicals

Trading Ideas

AAPL

Apple Stock Takes A Bite Out Of Investors As Siri Fumbles AI Race

<p><strong>Super Micro Computer, Inc. </strong>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) stock is trading higher on Wednesday after the company unveiled new Intel Xeon <a href="https://www.benzinga.com//node/44262166">6-Powered servers</a>.</p>
<p><strong>The Details:</strong> The servers are designed to enhance AI performance and efficiency at the edge, featuring over 40% more memory bandwidth and up to 144 CPU cores.</p>
<p>&#8220;As the demand for Edge AI solutions grows, businesses need highly reliable, compact systems that can process data at the edge in real-time,&#8221;&nbsp;said&nbsp;<strong>Charles Liang</strong>, president and CEO of Supermicro.&nbsp;</p>
<p>&#8220;Our latest generation of edge servers deliver advanced AI capabilities for enhanced efficiency and decision-making close to where the data is generated. With up to 2.5 times core count increase at the edge with improved performance per watt and per core, these new Supermicro compact systems are fully optimized for workloads such as Edge AI, telecom, networking, and CDN.&#8221;</p>
<p><strong>Related Link: <a href="https://www.benzinga.com/general/biotech/25/03/44283318/gilead-presents-new-hiv-treatment-and-cure-research-data">Gilead Presents New HIV Treatment And Cure Research Data</a></strong></p>
<p><strong>SMCI Price Action:</strong> At the time of writing, Super Micro stock is trading 5.17% higher at $42.97, according to data from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.</p>
<p><em>Image: Image via Shutterstock</em></p>


Movers

SMCI

What's Going On With Super Micro Computer Shares Wednesday?

<p><strong>Dogecoin </strong>(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>) has fallen 17% over the past seven days, reaching levels that some traders believe present a <a href="https://www.benzinga.com/money/dogecoin-doge-price-prediction">prime buying opportunity</a>.</p>
<p><figure class="wp-block-table"><br />
<table>
<tbody>
<tr>
<td><strong>Cryptocurrency</strong></td>
<td><strong>Price&nbsp;&nbsp;&nbsp;</strong></td>
<td><strong>Market Cap</strong></td>
<td><strong>24-Hour Trend</strong></td>
<td><strong>7-Day Trend</strong></td>
</tr>
<tr>
<td><strong>Dogecoin</strong> (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td>&nbsp;$0.1650</td>
<td>$24.5 billion</td>
<td>+2.3%&nbsp;</td>
<td>-17.3%&nbsp;</td>
</tr>
<tr>
<td><strong>Shiba Inu</strong> (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>)</td>
<td>&nbsp;$0.00001211</td>
<td>$7.1 billion</td>
<td>+3%</td>
<td>-7.4%&nbsp;</td>
</tr>
<tr>
<td><strong>Pepe</strong> (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">PEPE</a>)</td>
<td>&nbsp;$0.0<sub>5</sub>6478</td>
<td>$2.7 billion</td>
<td>+8.3%&nbsp;</td>
<td>-6.7%&nbsp;</td>
</tr>
</tbody>
</table>
<p></p></figure></p>
<p><strong>Trader Notes: </strong>Crypto analyst Kevin <a href="https://x.com/Kev_Capital_TA/status/1899641945879916576">explained</a> that Bitcoin is currently back-testing key technical levels, including the 0.5 Fibonacci retracement, macro trend lines and the 200-week SMA &amp; EMA, while the 3-day RSI is at historical lows. </p>
<p>If BTC holds its levels and macro conditions improve, he believes this could be the last chance to buy Dogecoin at a relatively cheap price with a strong risk-reward setup.</p>
<p>Crypto trader Wizz remains bullish, <a href="https://x.com/CryptoWizardd/status/1899546767135277563">stating</a> that DOGE is his biggest bag and predicting the meme coin could hit $1 or beyond this cycle.</p>
<p>Trader Tardigrade sees DOGE mirroring its previous bottom pattern, highlighting the RSI entering the oversold zone, a second lower low forming while RSI remains stable and a similar setup preceded past bull runs. </p>
<p>"If history repeats, an upcoming Bull Run is ahead," he stated.</p>
<p><figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"><br />
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><p lang="en" dir="ltr"><a href="https://twitter.com/hashtag/Dogecoin?src=hash&amp;ref_src=twsrc%5Etfw">#Dogecoin</a> follows the pattern of its last bottom &#x1f525;<a href="https://twitter.com/search?q=%24DOGE&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$DOGE</a> forms an initial low as the RSI falls into the oversold zone, then creates another lower low with a similar RSI reading in the same zone.<br /><br />If history repeats, an upcoming Bull Run is ahead &#x1f680; <a href="https://t.co/zxLPZrfkOq">pic.twitter.com/zxLPZrfkOq</a></p>
<p>&mdash; Trader Tardigrade (@TATrader_Alan) <a href="https://twitter.com/TATrader_Alan/status/1899773630235693064?ref_src=twsrc%5Etfw">March 12, 2025</a></p></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
<p></p></figure></p>
<p><strong>Statistics: </strong>In an X post on March 9, crypto analyst Ali Martinez <a href="https://x.com/ali_charts/status/1898831909066559507?ref_src=twsrc%5Etfw">reported</a> a 270% surge in active DOGE addresses over 24 hours, jumping from 71,750 to 264,000.</p>
<p>Coinglass data shows Dogecoin's open interest increased 5% to $1.4 billion in a single day, while liquidations over the past 24 hours stand at $9.17 million. </p>
<p>The majority of the liquidations remain short liquidations raising curiosity if the meme coin is in for a short-term correction.</p>
<p><strong>Community News: </strong>The SEC <a href="https://x.com/martypartymusic/status/1899548558568612254">announced</a> it will delay its decision on multiple crypto ETFs, which includes the Grayscale spot Dogecoin ETF.</p>
<p>Crypto Twitter is buzzing after the SEC accepted the application for the Bitwise DOGE ETF, signaling increasing institutional interest in meme coins.</p>
<p><strong>Read Next:&nbsp;</strong></p>
<ul>
<li><strong><a href="https://in.benzinga.com/markets/cryptocurrency/25/03/44260478/i-lost-everything-trader-turns-0-into-5-million-loses-it-all-with-meme-coins-that-were-supposed-to-become-the-next-dogecoin-shiba-inu"> &#8216;I Lost Everything&#8217;—Trader Turns 0 Into $5 Million, Loses It All With Meme Coins That Were Supposed To Become The Next Dogecoin, Shiba Inu</a></strong></li>
</ul>
<p><em>Image: Shutterstock</em></p>


Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$DOGE

$PEPE

$SHIB

Dogecoin Drops 17% In A Week: What Is Going On?

Magnachip Semiconductor shares are trading lower. The company reported Q4 financial results.

Press Releases

Waldencast plc Announces Board Appointments and Annual General Meeting

Waldencast plc Announces Third Quarter Fiscal 2024 Results Conference Call and Webcast

Earnings

Waldencast Reports Q3 2024 Financial Results

Waldencast Announces Participation in the ICR Conference 2025

Milk Makeup to Launch at Ulta Beauty This Spring

Waldencast Announces Participation in the 2025 IMCAS World Congress

Waldencast plc Announces Upcoming Earnings Release and Conference Call Dates

Health Care

General

Obagi Medical Announces the Launch of Latest Innovations in The SUZANOBAGIMD® Collection

Waldencast Announces Participation in the TD Cowen 2nd Annual Glowing Ahead: Beauty & Wellness Summit

Waldencast plc Announces Fourth Quarter and Fiscal Year 2024 Results Conference Call and Webcast

WALD

AXIL Brands

BellRing Brands

Coty

Big Tree Cloud Holdings Limited - Ordinary Shares

Big Tree Cloud Holdings

Estee Lauder Companies, Inc. (The) Common Stock

Estee Lauder Cos

e.l.f. Beauty

Edgewell Personal Care Company Common Stock

Edgewell Personal Care

FitLife Brands

Herbalife

Honest Co

Interparfums

Kenvue

Lifevantage

Medifast

Nature's Sunshine Products, Inc. - Common Stock

Natures Sunshine Products

Natural Health Trends Corp. - Commn Stock

Natural Health Trends

Nu Skin Enterprises

Olaplex Hldgs

Paranovus Entertainment Technology Ltd. - Class A Ordinary Shares

Paranovus Enter

Safety Shot

The Beauty Health Company - Class A Common Stock

Beauty Health

United-Guardian

Unilever

Usana Health Sciences

Yatsen Holding Limited American Depositary Shares, each representing twenty (20) Class A Ordinary Shares

Comments

Waldencast

空売り

Waldencast (NASDAQ:WALD) 株価情報, 空売り情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル